ExploreWatchlistsPricing
  1. JP-listed companies
  2. KISSEI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Total assets

KISSEI PHARMACEUTICAL CO.,LTD. (4547)

Market cap
¥230.7B
P/E ratio
15.8x
Kissei Pharmaceutical develops and manufactures prescription drugs while also operating subsidiaries in food products, IT services, and construction.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndTotal assets (Million JPY)YoY (%)
Mar 31, 2025244,059-6.47%
Mar 31, 2024260,929+17.96%
Mar 31, 2023221,200-7.09%
Mar 31, 2022238,087-11.45%
Mar 31, 2021268,861+15.99%
Mar 31, 2020231,794+8.56%
Mar 31, 2019213,522+0.20%
Mar 31, 2018213,087+14.07%
Mar 31, 2017186,801-3.38%
Mar 31, 2016193,345+6.54%
Mar 31, 2015181,484

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat